Telmisartan Attenuates Uric Acid-Induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
Authors:
Open Access
- 12 March 2019
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-12
Abstract
We examined whether and how uric acid induces epithelial to mesenchymal transition (EMT) in renal tubular cells, along with the mechanism by which telmisartan acts on uric acid-induced renal injury. Rat renal proximal tubular epithelial cells (NRK-52E) were exposed to various concentrations of uric acid in the presence or absence of telmisartan. Treatment with uric acid increased the expression ofα-SMA, decreased the expression of E-cadherin, and promoted EMT in NRK-52E cells. Uric acid treatment also led to increased endothelin-1 (ET-1) production, activation of extracellular-regulated protein kinase 1/2 (ERK1/2), and the upregulation of nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4). Use of ET-1 receptor inhibitor (BQ123 or BQ788) could inhibit uric acid-induced EMT in NRK-52E cells. Pretreatment with the ERK inhibitor (U0126 or PD98059) suppressed the release of ET-1 and EMT induced by uric acid. Additionally, pretreatment with a traditional antioxidant (diphenylene iodonium or apocynin) inhibited the activation of ERK1/2, release of ET-1, and uric acid-induced EMT in NRK-52E cells. These findings suggested that uric acid-induced EMT in renal tubular epithelial cells occurs through NADPH oxidase-mediated ERK1/2 activation and the subsequent release of ET-1. Furthermore, telmisartan (102nmol/L to 104nmol/L) inhibited the expression of NOX4, intracellular reactive oxygen species (ROS), activation of ERK1/2, and the release of ET-1 in a dose-dependent manner, thereby preventing uric acid-induced EMT in NRK-52E. In conclusion, telmisartan could ameliorate uric acid-induced EMT in NRK-52E cells likely through inhibition of the NADPH oxidase/ERK1/2/ET-1 pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81170679, 81400694, 2017060201010179, znpy2017044)
- National Natural Science Foundation of China (81170679, 81400694, 2017060201010179, znpy2017044)
- Wuhan Science and Technology Bureau (81170679, 81400694, 2017060201010179, znpy2017044)
- Wuhan University Science, Technology and Innovation Seed Fund (81170679, 81400694, 2017060201010179, znpy2017044)
This publication has 42 references indexed in Scilit:
- Endothelin‐1 and the kidney – beyond BPBritish Journal of Pharmacology, 2012
- Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic ratsCardiovascular Diabetology, 2012
- Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic miceHypertension Research, 2011
- Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling LoopJournal of Biological Chemistry, 2011
- Physiology of Endothelin and the Kidney2011
- Fibroblasts and myofibroblasts in renal fibrosisInternational Journal of Experimental Pathology, 2011
- Oxidative stress in early diabetic nephropathy: fueling the fireNature Reviews Endocrinology, 2010
- p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathwayAmerican Journal of Physiology-Renal Physiology, 2010
- Endothelin in Unilateral Ureteral Obstruction: Vascular and Cellular EffectsJournal of Urology, 2003
- Diabetes mellitus increases endothelin-1 gene transcription in rat kidneyKidney International, 2000